Observational studyAnnals of the American Thoracic Society2014

Inhaled amikacin for treatment of refractory pulmonary nontuberculous mycobacterial disease.

Kenneth N Olivier et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.